NSC |
Compound |
Enrichment |
Correlation |
NSC 716951 |
Null |
0.0342636096654271 |
-0.061980463 |
NSC 726267 |
Null |
0.0342636096654271 |
0.42794089 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0342636096654271 |
-0.17733282 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0342636096654271 |
0.12605944 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0342636096654271 |
-0.042915386 |
NSC 733504 |
Everolimus |
0.0342636096654271 |
0.3059044 |
NSC 737231 |
Null |
0.0342636096654271 |
-0.11712894 |
NSC 747461 |
Null |
0.0342636096654271 |
0.47768378 |
NSC 751152 |
3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone |
0.0342636096654271 |
-0.091377083 |
NSC 84074 |
Phosphonium, (3-bromopropyl)triphenyl- bromide |
0.0342636096654271 |
0.17407946 |